UAB Hematology Review 2021
Therapeutic Options for R/R MM: Single Agent vs. Doublets vs. Triplets, Summary for Triple Refractory Disease
By
UAB Hematology Review 2021
FEATURING
Kelly Godby
By
UAB Hematology Review 2021
FEATURING
Kelly Godby
Comments 0
Login to view comments.
Click here to Login
